FrancophonIA/ELRC3.0 huggingface dataset:
English: Nevirapine: exposure: 100% compared with historical data where nevirapine was administered alone.
Croatian: Nevirapin: izloženost 100% u usporedbi s povijesnim podacima kada je nevirapin primjenjivan sam.
English: Nevirapine is a NNRTI of HIV-1.
Croatian: Nevirapin je NNRTI HIV-a-1.
English: Prolonged-release tablets are not suitable for the 14-day lead-in phase for patients starting nevirapine.
Croatian: Tablete s produljenim oslobađanjem nisu prikladne za 14-dnevnu uvodnu fazu za bolesnike koji počinju terapiju nevirapinom.
English: Long-term efficacy appears to be most likely in patients whose nevirapine trough levels exceed 3.5 µg/ml.
Croatian: Dugotrajna djelotvornost najizglednija je u bolesnika u kojih vrijednosti nevirapina prelaze 3,5 µg/ml.
English: The ingested dose was 40 times the recommended dose of 2 mg/kg/day.
Croatian: Unešena doza bila je 40 puta viša od preporučene doze od 2 mg/kg/dan.
English: Inform your doctor about all other medicines you are taking before you start taking Viramune.
Croatian: Obavijestite svog liječnika o svim drugim lijekovima koje uzimate prije nego počnete uzimati Viramune.
English: 3 (6.3 % versus 1.2 % for men with CD4 counts <400 cells/mm
Croatian: (6,3% naspram 1,2% za muškarce s brojem CD4 <400 stanica/mm
English: Nevirapine is a non-competitive inhibitor of the HIV-1 reverse transcriptase, but it does not have a biologically significant inhibitory effect on the HIV-2 reverse transcriptase or on eukaryotic DNA polymerases , , , or .
Croatian: Nevirapin je nekompetitivan inhibitor HIV-1 reverzne transkriptaze, ali nema biološki značajan inhibitorni učinak na HIV-2 reverznu transkriptazu ili na eukariotske DNKpolimeraze , , , ili .
English: Patients should be advised of the need to take Viramune every day as prescribed.
Croatian: Bolesnike je potrebno upozoriti da je Viramune potrebno uzeti svaki dan kako je propisao liječnik.
English: - Africa
Croatian: - Afrika
English: PHARMACEUTICAL FORM AND CONTENTS 240 ml oral suspension
Croatian: OBLIK I SADRŽAJ 240 ml oralne suspenzije
English: For children
Croatian: Za djecu
English: In clinical studies, Viramune has been associated with an increase in HDL- cholesterol and an overall improvement in the total to HDL-cholesterol ratio.
Croatian: U kliničkim ispitivanjima Viramune je bio povezan s porastom HDL-kolesterola i ukupnim poboljšanjem omjera ukupnog i HDL-kolesterola.
English: Cartons containing 6 or 12 blister cards (60 or 120 tablets).
Croatian: Kutija sadrži 6 ili 12 blistera (60 ili 120 tableta).
English: Pharmacotherapeutic group: Antivirals for systemic use, non-nucleoside reverse transcriptase inhibitors, ATC code J05AG01.
Croatian: Farmakoterapijska skupina: Antivirusni lijekovi za sistemsku primjenu, nenukleozidni inhibitori reverzne transkriptaze, ATK oznaka: J05AG01.
English: Perinatal Transmission
Croatian: Perinatalni prijenos
English: Single dose nevirapine in mothers or infants may lead to reduced efficacy if an HIV treatment regimen using nevirapine is later instituted within 6 months or less in these patients.
Croatian: Jednokratna doza nevirapina kod majki ili djece može dovesti do smanjene djelotvornosti ako se režim liječenja HIV-a nevirapinom uvodi kasnije, u roku od 6 mjeseci ili kraćem spomenutim bolesnicima.
English: Adult patients:
Croatian: Odrasli bolesnici:
English: However, approximately 15 % of these patients with hepatic fibrosis had nevirapine trough concentrations above 9,000 ng/ml (2 fold the usual mean trough).
Croatian: Međutim, otpilike 15% tih bolesnika s fibrozom jetre imalo je koncentracije nevirapina na kraju dozirnog intervala iznad 9000 ng/ml (2 puta višu od uobičajenih prosječnih na kraju dozirnog intervala).
English: The score line is not intended for breaking the tablet.
Croatian: Urez nije namijenjen za lomljenje tablete.
English: Nervous system disorders Common headache
Croatian: Poremećaji živčanog sustava Često glavobolja
English: By stopping reverse transcriptase from working, Viramune helps control HIV-1 infection.
Croatian: Zaustavljanjem djelovanja reverzne transkriptaze, Viramune pomaže u kontroli HIV-1 infekcije.
English: 6.6 Special precautions for disposal and other handling Instructions for administration:
Croatian: 6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Upute za primjenu:
English: Viramune prolonged-release tablets may be dosed based on a patient's weight or body surface area (BSA).
Croatian: Viramune tablete s produljenim oslobađanjem mogu se dozirati na osnovi tjelesne težine ili tjelesne površine (BSA) bolesnika.
English: Clinical chemistry tests, which include liver function tests, should be performed prior to initiating nevirapine therapy and at appropriate intervals during therapy.
Croatian: Klinički laboratorijski testovi, koji uključuju testove jetrene funkcije, izvode se prije početka terapije nevirapinom i u odgovarajućim intervalima tijekom terapije.
English: Virologic failure - Never suppressed through week 48 - Rebound
Croatian: Virološki neuspjeh - Bez suprimacije tijekom 48 tjedana
English: Since neither body weight nor Body Mass Index (BMI) had influence on the clearance of nevirapine, the effect of gender cannot be explained by body size.
Croatian: S obzirom da niti tjelesna težina niti indeks tjelesne mase (BMI) nisu utjecali na klirens nevirapina, učinak spola ne može se objasniti veličinom tijela.
English: Signs of osteonecrosis are joint stiffness, aches and pains (especially of the hip, knee and shoulder) and difficulty in movement.
Croatian: Znakovi osteonekroze su ukočenost zglobova, bolovi (pogotovo u području kuka, koljena i ramena) te teškoće u kretanju.
English: If patients report such an event, reassurance should be obtained on the lack of impact on therapeutic response.
Croatian: Ako bolesnici prijave opisani događaj, potrebno je potvrditi odsustvo njegovog utjecaja na terapijski odgovor.
English: Patients with hepatic impairment should be monitored carefully for evidence of medicinal product induced toxicity.
Croatian: Bolesnici s oštećenjem jetre trebali bi se pažljivo pratiti u svrhu dokaza toksičnih učinaka induciranih lijekom.
English: The absorption of nevirapine is not affected by food, antacids or medicinal products which are formulated with an alkaline buffering agent.
Croatian: Na apsorpciju nevirapina ne utječu hrana, antacidi, ili lijekovi koji su formulirani s alkalnim puferima.
English: What you need to know before you take Viramune
Croatian: Što morate znati prije nego počnete uzimati Viramune
English: Nevirapine is about 60 % bound to plasma proteins in the plasma concentration range of 1-10 µg/ml.
Croatian: Nevirapin je oko 60% vezan na proteine plazme pri plazmatskim koncentracijama u rasponu 1-10 µg/ml.
English: - Europe
Croatian: - Europa
English: An increase in the dose of lopinavir/ritonavir to 533/133 mg (4 capsules) or 500/125 mg (5 tablets with 100/25 mg each) twice daily with food is recommended in combination with Viramune.
Croatian: Povišenje doze lopinavir/ritonavira na 533/133 mg (4 kapsule) ili 500/125 mg (5 tableta s 100/25 mg svaka) dvaput dnevno s hranom preporučuje se u kombinaciji s Viramuneom.
English: The bottle can be kept sealed with the lid of the plastic adapter.
Croatian: Boca se može držati zatvorena poklopcem plastičnog nastavka.
English: Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term exposure to combination antiretroviral therapy (CART).
Croatian: Prijavljeni su slučajevi osteonekroze, osobito u bolesnika s poznatim rizičnim faktorima, uznapredovalom HIV-bolešću ili dugotrajnom izloženošću kombiniranoj antiretrovirusnoj terapiji (CART).
English: In this study, the multiple dose pharmacokinetic disposition of nevirapine and the five oxidative metabolites were not altered.
Croatian: U ovoj studiji, izloženost farmakokinetici višestruke doze nevirapina i pet oksidativnih metabolita nije se mijenjala.
English: Pharmacokinetic data on 33 patients (age range 0.77 - 13.7 years) in the intensive sampling group demonstrated that clearance of nevirapine increased with increasing age in a manner consistent with increasing body surface area.
Croatian: Farmakokinetički podaci za 33 bolesnika (dob 0,77-13,7 godina) u skupini u kojoj se intenzivno uzimalo uzorke, pokazali se da se klirens nevirapina povećava s dobi sukladno povećanju površine tijela.
English: Nevirapine has not been specifically investigated in patients over the age of 65.
Croatian: Nevirapin nije posebno ispitivan u bolesnika iznad 65 godina starosti.
English: The overall percentage of treatment responders observed in study 1100.1486 (including lead-in phase), regardless of the formulation is 793/1,068 = 74.3%.
Croatian: Ukupni postotak osoba koje su odgovorile na liječenje opažen u ispitivanju 1100.1486 (uključujući uvodno razdoblje), bez obzira na formulaciju, je 793/1 068 = 74,3 %.
English: If you are taking nevirapine and zidovudine concomitantly please inform your doctor since he might need to check your white blood cells.
Croatian: Ako istodobno uzimate nevirapin i zidovudin, molimo, obavijestite svog liječnika jer će Vas možda trebati uputiti na provjeru bijelih krvnih stanica.
English: You must take it with at least two other antiretroviral medicines.
Croatian: Potrebno ga je uzimati uz najmanje dva druga antiretrovirusna lijeka.
English: Itraconazole Cmax  0.62
Croatian: Itrakonazol Cmax  0,62
English: Do not take Viramune after an exposure to HIV unless you have been diagnosed with HIV and instructed to do so by your doctor.
Croatian: Ne uzimajte Viramune nakon izlaganja HIV-u, osim ako Vam nije postavljena dijagnoza HIV-a te Vas liječnik na to uputi.
English: What Viramune is and what it is used for What do you need to know before you take Viramune How to take Viramune
Croatian: Što je Viramune i za što se koristi Što morate znati prije nego počnete uzimati Viramune Kako uzimati Viramune
English: The recommended oral doses for paediatric patients based upon their weight are described in the table below.
Croatian: Preporučene peroralne doze za pedijatrijske bolesnike na osnovi njihove težine opisane su u donjoj tablici.
English: reduction in red blood cells (anaemia), which may be related to nevirapine therapy, is also more commonly observed in children.
Croatian: Smanjenje broja crvenih krvnih stanica (anemija), koje može biti povezano s terapijom nevirapinom, također je češće opaženo u djece.
English: Patients with pre-existing liver dysfunction including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.
Croatian: Bolesnici s već postojećom disfunkcijom jetre, uključujući kronični aktivni hepatitis, imaju povećanu učestalost abnormalnosti jetrene funkcije tijekom kombinirane antiretrovirusne terapije te moraju biti praćeni prema standardnoj praksi.
English: Patients should be informed that hepatic reactions are a major toxicity of nevirapine requiring a close monitoring during the first 18 weeks.
Croatian: Bolesnici moraju biti obaviješteni da su jetrene reakcije važan oblik toksičnosti nevirapina, što zahtijeva pomno praćenje tijekom prvih 18 tjedana.
English: Oral hormonal contraceptives should not be used as the sole method of contraception in women taking Viramune (see section 4.4).
Croatian: Oralni hormonski kontraceptivi ne smiju se primjenjivati kao jedina metoda kontracepcije u žena koje uzimaju Viramune (vidjeti dio 4.4).
English: INTEGRASE INHIBITORS Elvitegravir/ cobicistat
Croatian: INHIBITORI INTEGRAZE Elvitegravir/kobicistat
English: Weight and metabolic parameters:
Croatian: Tjelesna težina i metabolički parametri
English: The geometric mean nevirapine Cmin,ss was 2,770 ng/ml.
Croatian: Geometrijska srednja vrijednost za nevirapin Cmin,ss bila je 2 770 ng/ml.
English: There was also accumulation of nevirapine hydroxy-metabolites in plasma.
Croatian: Također je došlo do akumulacije hidroksi metabolita nevirapina u plazmi.
English: Viramune is also available as 400 mg prolonged-release tablets for a once daily usage after the lead-in phase for children depending on their age and body weight (body surface area).
Croatian: Viramune je također dostupan u obliku 400 mg tableta s produljenim oslobađanjem za primjenu jednom dnevno nakon uvodnog razdoblja za djecu ovisno o njihovoj dobi i tjelesnoj težini (površini tijela).
English: - or have a body surface area above 1.25 square metres.
Croatian: - čija je površina tijela veća od 1,25 kvadratnih metara.
English: Co-administration of boceprevir with medicines that induce or inhibit CYP3A4/5 could increase or decrease exposure.
Croatian: Istodobna primjena boceprevira s lijekovima koji induciraju ili inhibiraju CYP3A4/5 može povećati ili smanjiti izloženost.
English: Skin and subcutaneous tissues
Croatian: Koža i potkožna tkiva
English: Six cases of Stevens-Johnson Syndrome were reported in the study; all but one occurred within the first 30 days of nevirapine treatment.
Croatian: Prijavljeno je šest slučajeva Stevens-Johnsonovog sindroma u ispitivanju, a svi osim jednog su se pojavili unutar prvih 30 dana liječenja nevirapinom.
English: The total daily dose at any time during treatment should not exceed 400 mg for any patient.
Croatian: Ukupna dnevna doza niti u jednom trenutku tijekom liječenja ne smije prelaziti 400 mg za svakog bolesnika.
English: Therefore, caution should be used in concomitant administration.
Croatian: Stoga je nužan oprez pri istodobnoj primjeni.
English: Telaprevir is metabolised in the liver by CYP3A and is a P-glycoprotein substrate.
Croatian: Telaprevir se metabolizira u jetri putem CYP3A te je supstrat P-glikoproteina.
English: Pharmacokinetic results suggest caution should be exercised when nevirapine is administered to patients with moderate hepatic dysfunction (Child-Pugh B).
Croatian: Farmakokinetički rezultati ukazuju da je nužan oprez kada se nevirapin primjenjuje bolesnicima s umjerenom disfunkcijom jetre (Child-Pugh B).
English: For paediatric patients aged 3 years and older, 100 mg prolonged-release tablets are available.
Croatian: Za pedijatrijske bolesnike u dobi 3 ili više godina starosti, dostupne su 100 mg tablete s produljenim oslobađanje.
English: Some patients have reported the occurrence of remnants in faeces which may resemble intact tablets.
Croatian: Neki su bolesnici prijavili pojavu ostataka u stolici koji mogu nalikovati čitavim tabletama.
English: Carbomer
Croatian: karbomer,
English: Viramune should only be used with at least two other antiretroviral agents (see section 5.1).
Croatian: Viramune se primjenjuje samo s najmanje dva druga antiretrovirusna lijeka (vidjeti dio 5.1).
English: The following patients are at increased risk of developing liver problems: - women - infected with hepatitis B or C - abnormal liver function tests
Croatian: Slijedeće skupine bolesnika su pod povećanim rizikom razvoja problema s jetrom: - žene - osobe inficirane hepatitisom B ili C - osobe s poremećenim rezultatima testova jetrene funkcije
English: Liver test monitoring should be performed if the patient experiences signs or symptoms suggestive of hepatitis and/or hypersensitivity.
Croatian: Praćenje jetrenih testova je potrebno ukoliko se kod bolesnika pojave znakovi ili simptomi koji ukazuju na hepatitis i/ili preosjetljivost.
English: Each bottle contains 2.4 g of nevirapine (as hemihydrate) in 240 ml of Viramune oral suspension.
Croatian: Jedna boca sadrži 2,4 g nevirapina (u obliku hemihidrata) u 240 ml Viramune oralne suspenzije.
English: The lead-in period is not required if the patient is already on chronic Viramune 200 mg tablets or Viramune oral suspension twice daily treatment.
Croatian: Uvodno razdoblje nije potrebno ako je bolesnik već na kroničnom liječenju Viramune 200 mg tabletama ili Viramune oralnom suspenzijom dvaput dnevno.
English: Do not take Viramune - if you are allergic to nevirapine or any of the other ingredients of this medicine (listed in section
Croatian: Nemojte uzimati Viramune - ako ste alergični na nevirapin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6).
English: Abnormal liver function tests have been reported with nevirapine, some in the first few weeks of therapy.
Croatian: Prijavljeni su abnormalni rezultati testova jetrene funkcije uz primjenu nevirapina, a neki od njih u prvih nekoliko tjedana terapije.
English: This includes some cases of inflammation of the liver (hepatitis), which can be sudden and intense (fulminant hepatitis), and liver failure, which can be both fatal.
Croatian: Ovo uključuje neke slučajeve upale jetre (hepatitis), koje mogu biti iznenadne i intenzivne (fulminantni hepatitis), te zatajanje jetre, od kojih oboje mogu biti fatalne.
English: The majority of rashes associated with nevirapine occur within the first 6 weeks of initiation of therapy.
Croatian: Većina osipa povezanih s nevirapinom pojavljuju se unutar prvih 6 tjedana od početka terapije.
English: This also includes safety data for patient visits in the post-week 144 open label extension (which patients in either treatment group who completed the 144 week blinded phase could enter).
Croatian: Ovo je također uključivalo podatke o sigurnosti za posjete bolesnika nakon 144 tjedna u „otvorenom“ produljenju (u koje su mogli biti uključeni bolesnici iz svih liječenih skupina koji su završili 144 tjedna „slijepe“ faze).
English: Furthermore, combining the following compounds with Viramune is not recommended: efavirenz, ketoconazole, delavirdine, etravirine, rilpivirine, elvitegravir (in combination with cobicistat), atazanavir (in combination with ritonavir), boceprevir; fosamprenavir (if not co-administered with low dose ritonavir) (see section 4.5).
Croatian: Nadalje, ne preporučuje se kombinacija sljedećih tvari s Viramuneom: efavirenz, ketokonazol, delavirdin, etravirin, rilpivirin, elvitegravir (u kombinaciji s kobicistatom), atazanavir (u kombinaciji s ritonavirom), boceprevir, fosamprenavir (ako se primjenjuje istovremeno uz nisku dozu ritonavira) (vidjeti dio 4.5).
English: Results of in vitro studies showed a weak antagonism of nevirapine by
Croatian: Rezultati in vitro ispitivanja pokazali su slab antagonizam nevirapina s
English: Viramune is also available as smaller prolonged-release tablets (for children 3 years of age and above after the lead-in period) or as an oral suspension (for all age groups).
Croatian: Viramune je također dostupan u obliku slabijih tableta s produljenim oslobađanjem (za djecu 3 i više godina starosti nakon uvodnog razdoblja) ili u obliku oralne suspenzije (za sve dobne skupine)
English: Elderly Nevirapine has not been specifically investigated in patients over the age of 65.
Croatian: Starije osobe Nevirapin nije posebno ispitivan u bolesnika starijih od 65 godina.
English: Similar EC50 values are obtained when the antiviral activity of nevirapine is measured in peripheral blood mononuclear cells, monocyte derived macrophages or lymphoblastoid cell line.
Croatian: Slične vrijednosti EC50 dobivene su i kada je antivirusna aktivnost nevirapina mjerena u mononuklearnim stanicama iz periferne krvi, makrofagima iz monocita ili limfoblastoidnoj staničnoj liniji.
English: If you have a renal or hepatic dysfunction of any degree please use only Viramune 200 mg tablets or Viramune 50 mg/5 ml oral suspension.
Croatian: Ako imate disfunkciju bubrega ili jetre bilo kojeg stupnja, molimo, primjenjujte isključivo Viramune 200 mg tablete ili Viramune 50 mg/5 ml oralnu suspenziju.
English: If your doctor has told you that you (or your child) have an intolerance to some sugars or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.
Croatian: Ako Vam je liječnik rekao da Vi (ili Vaše dijete) ne podnosite(podnosi) neke šećere ili ako Vam je dijagnosticirano nasljedno nepodnošenje fruktoze, rijetki nasljedni poremećaj kod kojeg bolesnik ne može razgraditi fruktozu, obratite se liječniku prije nego Vi (ili Vaše dijete) uzmete(uzme) ili primite(primi) ovaj lijek.
English: Percent change n=406
Croatian: Postotak promjene n=406
English: ANTIVIRALS FOR CHRONIC HEPATITIS B AND C Adefovir
Croatian: ANTIVIRUSNI LIJEKOVI ZA LIJEČENJE KRONIČNOG HEPATITISA B I C Adefovir
English: The nevirapine twice daily regimen and the efavirenz regimen were not significantly different (p= 0.091) in terms of efficacy as measured by treatment failure, or any component of treatment failure including virological failure.
Croatian: Nevirapin u režimu doziranja dva puta dnevno i režim doziranja efavirenza nisu se značajno razlikovali (p=0,091) u smislu djelotvornosti mjerene terapijskim neuspjehom ili nekom od komponenti terapijskog neuspjeha, uključujući virološki neuspjeh.
English: Coadministration of telaprevir and medicinal products that induce CYP3A and/or P-gp may decrease telaprevir plasma concentrations.
Croatian: Istodobna primjena telaprevira i lijekova koji induciraju CYP3A i/ili P-gp može smanjiti koncentracije telaprevira u plazmi.
English: Other nevirapine formulations, such as immediate-release tablets or oral suspension should be used (see section 4.2).
Croatian: Primjenjuju se druge formulacije nevirapina, kao što su tablete s trenutnim oslobađanjem ili oralna suspenzija (vidjeti dio 4.2).
English: The inducing effect may persist for at least 2 weeks after cessation of treatment with St. John‘s Wort.
Croatian: Inducirajući učinak se može održati najmanje 2 tjedna nakon prekida liječenja gospinom travom.
English: Lipids, Change from baseline Changes from baseline in fasting lipids are shown in Table 4.
Croatian: Lipidi, promjena u odnosu na početne vrijednosti Promjene u odnosu na početne vrijednosti lipida natašte prikazane su u tablici 4.
English: Time to emergence of nevirapine resistance in cell culture was not altered when selection included nevirapine in combination with several other NNRTIs.
Croatian: Vrijeme do pojave otpornosti nevirapina u staničnoj kulturi nije se promijenilo kada se selekcija sojeva temeljila na kombinaciji nevirapina i nekoliko drugih NNRTI-a.
English: Patients who are already on immediate-release tablets or oral suspension can switch to prolongedrelease tablets without lead-in period.
Croatian: Bolesnici koji su već na tabletama s trenutnim oslobađanjem ili oralnoj suspenziji mogu se prebaciti na tablete s produljenim oslobađanjem bez uvodnog razdoblja.
English: Viramune prolonged-release tablets should only be used after a two-week treatment with another type of Viramune (immediate-release tablets or suspension) unless you are currently on Viramune and are switching to the prolonged-release form.
Croatian: Viramune tablete s produljenim oslobađanjem se primjenjuju isključivo nakon dvotjednog liječenja drugim oblikom Viramunea (tablete s trenutnim oslobađanjem ili suspenzija), osim ako ste trenutno na Viramuneu i prebacujete se na oblik s produljenim oslobađanjem.
English: Median age was 34 years and about 64 % were male patients, median CD4 cell count was 170 and 190 cells per mm
Croatian: Medijan dobi bio je 34 godine, a oko 64% bolesnika bili su muškarci, medijan broja CD4 stanica bio je 170 i 190 stanica po mm
English: Viramune 400 mg prolonged-release tablets can be taken by children if they: - are  8 years of age and weigh 43.8 kg or more - are older than 3 years of age and below 8 years of age and weigh 25 kg or more - have a body surface area of 1.17 square metres or above.
Croatian: Viramune 400 mg tablete s produljenim oslobađanjem mogu uzimati djeca ako: - su ≥ 8 godina starosti i teže 43,8 kg ili više - su stariji od 3 i mlađi od 8 godina starosti te teže 25 kg ili više - imaju površinu tijela 1,17 kvadratnih metara ili više
English: ANTI-INFECTIVES ANTIRETROVIRALS NRTIs
Croatian: ANTIMIKROBNI LIJEKOVI ANTIRETROVIRUSNI
English: Viramune oral suspension is a white to off-white homogenous suspension.
Croatian: Viramune oralna suspenzija je bijela do bjelkasta homogena suspenzija.